Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Historical Holders from Q1 2023 to Q1 2025

Symbol
CANF on NYSE
CUSIP
13471N300
Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
3.87B
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
114K
Holdings value
$186K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
13
Number of buys
2
Number of sells
-4
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Orca Capital AG 9.7% $589M 375M Orca Capital AG Apr 14, 2025
ARMISTICE CAPITAL, LLC 4.99% $687K 440K Armistice Capital, LLC Dec 31, 2024

Institutional Holders of Can-Fite BioPharma Ltd. - Ordinary Shares, no par value (CANF)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 41.3K $61.1K +$16.9K $1.48 2
2024 Q4 114K $186K -$1.33M $1.63 13
2024 Q3 754K $1.52M +$243K $2.01 11
2024 Q2 628K $1.62M +$393K $2.58 11
2024 Q1 478K $1.06M +$498K $2.22 8
2023 Q4 244K $536K +$353K $2.20 8
2023 Q3 67.6K $179K +$34.5K $2.65 7
2023 Q2 54.6K $168K -$705K $3.07 5
2023 Q1 368K $843K +$843K $2.29 6